James N. Topper
InvestorManaging Partner at Frazier Life Sciences
Palo Alto
FoundedAlcrestaAllena PharmaceuticalsAlpine Immune SciencesAnaptysBioAptinyxAtterocor
About
James (Jamie) Topper co-leads Frazier's Life Sciences team as a Managing Partner, having joined the firm in 2003 and opened its first California office. Over more than two decades there, he has led or co-led investments in over 60 therapeutics-focused companies. Before joining Frazier, he headed cardiovascular R&D at Millennium Pharmaceuticals and served as VP of Biology at COR Therapeutics, and previously held faculty positions at Stanford and Harvard Medical School. He earned an M.D. and Ph.D. in Biophysics from Stanford and a B.S. from the University of Michigan.
Invests in
Biotech
Deals · 14
AtterocorBoard seat
via Frazier Life Sciences · filed Dec 2017 · $59.1M raise
AlcrestaBoard seat
via Frazier Life Sciences · filed Oct 2016 · $50.9M raise
AptinyxBoard seat
via Frazier Life Sciences · filed May 2016 · $65M raise
Merganser BiotechBoard seat
via Frazier Life Sciences · filed Apr 2016 · $17.1M raise
Allena PharmaceuticalsBoard seat
via Frazier Life Sciences · filed Dec 2015 · $53M raise
AnaptysBioBoard seat
via Frazier Life Sciences · filed Jul 2015 · $40.8M raise
ChanRxBoard seat
via Frazier Life Sciences · filed Feb 2015 · $31.9M raise
Alpine Immune SciencesLed round
AlnaraLed round
CoTherixLed round
InclineLed round
MavupharmaLed round
PortolaLed round
RempexLed round
Attribution from SEC filings, press coverage, and firm rosters.
